Supreme Court Keeps CMS Vaccine Requirement Alive Nationwide

Polsinelli
Contact

Polsinelli

Less than one week after hearing oral arguments, the U.S. Supreme Court has stayed injunctions against the Centers for Medicare & Medicaid Services (“CMS”) Omnibus COVID-19 Health Care Staff Vaccination Rule (“Vaccine Requirement”). As a result of the Court’s order, preliminary injunctions that had prevented CMS from enforcing the Vaccine Requirement in half of U.S. states will be stayed and CMS may implement the Vaccine Requirement in all states while the cases, originating in Missouri and Louisiana, continue their substantive courses. Those cases will proceed in the U.S. Courts of Appeals for the Fifth and Eighth Circuits and could once again find their way to the nation’s highest court in the future.

The Court granted the federal government’s request to stay the preliminary injunctions, finding that CMS does have the statutory authority to implement the Vaccine Requirement, likening it to long-standing infection control procedures and other conditions mandated for facilities participating in the Medicare and Medicaid programs. Additionally, the Court concluded that the Vaccine Requirement did not violate the APA or other CMS-specific rule-making standards.

Under guidance previously issued by CMS, staff in covered health care facilities in states not challenging the Vaccine Requirement must have received at least one dose of COVID-19 vaccine, or have been granted a qualifying exemption, by January 27, 2022 in for the facility to be considered compliant. CMS released a statement indicating that it was “pleased” and that the Court’s decision “will enable [CMS] to fully implement this rule.”

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Polsinelli

Written by:

Polsinelli
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Polsinelli on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide